Fig. 11. Progeny of teloblasts injected with AS-Hro-eve MO exhibit dramatic variability in the brightness of inherited lineage tracer. Digital fluorescence images of an intact embryo (A) and a sectioned one (B,C) in which one N teloblast had been injected with MM-Hro-eve MO and FDA (green) and the other with AS-Hro-eve MO and RDA (red) at stage 7; the injected embryos were fixed and counterstained with Hoechst 33258 (blue) 24 hours after the injections. Blast cells derived from teloblasts injected with MM-Hro-eve MO are uniformly labeled (A,B), whereas those derived from teloblasts injected with AS-Hro-eve MO exhibit marked cell-to-cell differences in the intensity (A,C). Scale bar: 50 µm.

Return to article